Literature DB >> 27752928

Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures.

M Gálfi1, M Radács1, Zs Molnár1, I Budai1, G Tóth2, A Pósa3, K Kupai3, Z Szalai3, R Szabó3, H A Molnár4, J Gardi5, Ferenc A László6, Cs Varga3.   

Abstract

The effects of ghrelin on vasopressin and oxytocin secretion were studied in 13-14-day cell cultures of isolated rat neurohypophyseal tissue. The vasopressin and oxytocin contents of the supernatant were determined by radioimmunoassay after a 1- or 2-h incubation. Significantly increased levels of vasopressin and oxytocin production were detected in the cell culture media following ghrelin administration, depending on the ghrelin doses. The oxytocin level proved to be more elevated than that of vasopressin. The increase of vasopressin and oxytocin secretion could be totally blocked by previous administration of the ghrelin receptor antagonist ([D-Lys3]-growth hormone-releasing peptide-6). Application of the ghrelin receptor antagonist after ghrelin administration proved ineffective. The results indicate that vasopressin and oxytocin release is influenced directly by the ghrelin system, and the effects of ghrelin on vasopressin and oxytocin secretion from the neurohypophyseal tissue in rats can occur at the level of the posterior pituitary. Our observations lend support to the view that neurohypophysis contains ghrelin receptors.

Entities:  

Keywords:  Ghrelin; Ghrelin receptor antagonist; Neurohypophyseal cell culture; Oxytocin; Vasopressin

Mesh:

Substances:

Year:  2016        PMID: 27752928     DOI: 10.1007/s12031-016-0850-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  56 in total

1.  [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis.

Authors:  S D Katugampola; Z Pallikaros; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Role of ghrelin in the regulation of vasopressin release in conscious rats.

Authors:  Seiji Ishizaki; Takashi Murase; Yoshihisa Sugimura; Satoshi Kakiya; Hisashi Yokoi; Kazushige Tachikawa; Hiroshi Arima; Yoshitaka Miura; Yutaka Oiso
Journal:  Endocrinology       Date:  2002-05       Impact factor: 4.736

3.  Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells.

Authors:  Kazunori Kageyama; Yukiko Kumata; Kanako Akimoto; Shinobu Takayasu; Naoki Tamasawa; Toshihiro Suda
Journal:  Stress       Date:  2011-03-27       Impact factor: 3.493

4.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

5.  Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures.

Authors:  M Gálfi; T Janáky; R Tóth; G Prohászka; A Juhász; C Varga; F A László
Journal:  Regul Pept       Date:  2001-04-02

6.  Rats with physically disconnected hypothalamo-pituitary tracts no longer contain vasopressin-oxytocin gene transcripts in the posterior pituitary lobe.

Authors:  E Mohr; A Zhou; N A Thorn; D Richter
Journal:  FEBS Lett       Date:  1990-04-24       Impact factor: 4.124

7.  Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins.

Authors:  Yun Zhu; Yoshihiro Miwa; Akihiro Yamanaka; Toshihiko Yada; Megumi Shibahara; Yoichiro Abe; Takeshi Sakurai; Katsutoshi Goto
Journal:  J Pharmacol Sci       Date:  2003-07       Impact factor: 3.337

8.  Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release.

Authors:  A Torsello; M Luoni; F Schweiger; R Grilli; M Guidi; E Bresciani; R Deghenghi; E E Müller; V Locatelli
Journal:  Eur J Pharmacol       Date:  1998-11-06       Impact factor: 4.432

9.  Plasma arginine-8-vasopressin responses to osmotic or histamine stimulation contribute to the differential diagnosis of central diabetes insipidus.

Authors:  F Laczi; T Iványi; J Julesz; T Janáky; F A László
Journal:  Acta Endocrinol (Copenh)       Date:  1986-10

10.  Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.

Authors:  A M Mozid; G Tringali; M L Forsling; M S Hendricks; S Ajodha; R Edwards; P Navarra; A B Grossman; M Korbonits
Journal:  Horm Metab Res       Date:  2003-08       Impact factor: 2.936

View more
  2 in total

1.  Electrophysiological Effects of Ghrelin in the Hypothalamic Paraventricular Nucleus Neurons.

Authors:  Raoni C Dos-Santos; Hanna M Grover; Luís C Reis; Alastair V Ferguson; André S Mecawi
Journal:  Front Cell Neurosci       Date:  2018-08-24       Impact factor: 5.505

2.  Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse Model.

Authors:  Juan A Rodriguez; Emily C Bruggeman; Bharath K Mani; Sherri Osborne-Lawrence; Caleb C Lord; Henry F Roseman; Hannah L Viroslav; Prasanna Vijayaraghavan; Nathan P Metzger; Deepali Gupta; Kripa Shankar; Claudio Pietra; Chen Liu; Jeffrey M Zigman
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.